news.pr
Puerto Rico, reported daily.
Thursday, November 5, 2026 · UTC
Puerto Rico, Pa'l Mundo

Puerto Rico courts Taiwan's biopharma makers - in Taiwan

An InvestPR delegation spent a week in Taipei working the island's next manufacturing opening.

Diego Pastrana Colón
Global Desk Correspondent
Share on X
Stands on 6 placed sources from 2 publishers.
An Invest Puerto Rico-led delegation spent one week in Taiwan in September, working directly with the island's economic development agencies. [1] The prize it is chasing: more of what PharmaEssentia already brought. The Taiwanese biopharmaceutical company became the first of its country to manufacture in Puerto Rico, formalizing a $46 million investment in March 2026. [2][3] InvestPR's pitch to the next wave of Taiwanese manufacturers leans on jurisdiction and price: goods made in Puerto Rico carry the "Made in USA" designation, and qualifying activities carry a 4% fixed corporate income tax rate under Act 60. [4][5] "Strategic economic fit" is how InvestPR chief executive Ella Woger puts it. [6]
Proof6 sources · 2 publishers · signed
What this stands on
  1. An Invest Puerto Rico led delegation spent one week in Taiwan in September. · elnuevodia.comPuerto Rico
  2. PharmaEssentia is the first Taiwanese biopharmaceutical company to manufacture in Puerto Rico. · investpr.org
  3. PharmaEssentia formalized a $46 million investment in Puerto Rico in March 2026. · investpr.org
  4. Goods manufactured in Puerto Rico carry the "Made in USA" designation. · investpr.org
  5. Qualifying activities in Puerto Rico have a 4% fixed corporate income tax rate under Act 60. · investpr.org
  6. Ella Woger stated Puerto Rico and Taiwan have a strategic economic fit. · elnuevodia.comPuerto Rico
The one we could place publishes from Puerto Rico. 1 could not be placed by their address. None is an official body: that part stands on reporting, not on the underlying document or transcript.